Biocytogen Pharmaceuticals (Beijing) Co (HKSE:02315) FCF Yield % : -3.06 (As of Dec. 15, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Biocytogen Pharmaceuticals (Beijing) Co FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Biocytogen Pharmaceuticals (Beijing) Co's Trailing 12-Month Free Cash Flow is HK$-96.7 Mil, and Market Cap is HK$3,158.9 Mil. Therefore, Biocytogen Pharmaceuticals (Beijing) Co's FCF Yield % for today is -3.06%.

The historical rank and industry rank for Biocytogen Pharmaceuticals (Beijing) Co's FCF Yield % or its related term are showing as below:

HKSE:02315' s FCF Yield % Range Over the Past 10 Years
Min: -15.2 Med: -6.92 Max: -3.03
Current: -3.06

During the past 4 years, the highest FCF Yield % of Biocytogen Pharmaceuticals (Beijing) Co was -3.03%. The lowest was -15.20%. And the median was -6.92%.

HKSE:02315's FCF Yield % is ranked better than
74.25% of 1507 companies
in the Biotechnology industry
Industry Median: -12.96 vs HKSE:02315: -3.06

Biocytogen Pharmaceuticals (Beijing) Co's FCF Margin % for the quarter that ended in Jun. 2024 was 1.75%.

Biocytogen Pharmaceuticals (Beijing) Co FCF Yield % Historical Data

The historical data trend for Biocytogen Pharmaceuticals (Beijing) Co's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biocytogen Pharmaceuticals (Beijing) Co FCF Yield % Chart

Biocytogen Pharmaceuticals (Beijing) Co Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

FCF Yield %

-5.92

-4.66

Biocytogen Pharmaceuticals (Beijing) Co Semi-Annual Data
	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
FCF Yield %	Get a 7-Day Free Trial			-	-6.46	-2.81	-4.38	0.51

Competitive Comparison of Biocytogen Pharmaceuticals (Beijing) Co's FCF Yield %

For the Biotechnology subindustry, Biocytogen Pharmaceuticals (Beijing) Co's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biocytogen Pharmaceuticals (Beijing) Co's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biocytogen Pharmaceuticals (Beijing) Co's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Biocytogen Pharmaceuticals (Beijing) Co's FCF Yield % falls into.

Biocytogen Pharmaceuticals (Beijing) Co FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Biocytogen Pharmaceuticals (Beijing) Co's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-222.326	/	4771.035
	=	-4.66%

Biocytogen Pharmaceuticals (Beijing) Co's annualized FCF Yield % for the quarter that ended in Jun. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	7.725	*	2	/	3047.3775
	=	0.51%

Biocytogen Pharmaceuticals (Beijing) Co FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Biocytogen Pharmaceuticals (Beijing) Co FCF Yield % Related Terms

Thank you for viewing the detailed overview of Biocytogen Pharmaceuticals (Beijing) Co's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Biocytogen Pharmaceuticals (Beijing) Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biocytogen Pharmaceuticals (Beijing) Co Ltd (HKSE:02315) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

I54:Germany

Address

12 Baoshen South Street, Daxing Bio-Medicine Industry Park, Daxing District, Beijing, CHN

Website

https://www.biocytogen.com.cn

Biocytogen Pharmaceuticals (Beijing) Co Ltd is a biopharmaceutical and pre-clinical research services company. It has two Core Products, YH003 and YH001. YH003 is a recombinant humanized agonistic anti-Cluster of Differentiation 40 (CD40) Immunoglobulin G2 (IgG2) monoclonal antibody and YH001 is a recombinant humanized anti-CTLA-4, a protein receptor expressed constitutively on T cells that functions as an immune checkpoint and downregulates immune responses, Immunoglobulin G1 (IgG1) monoclonal antibody. YH003 is being developed for pancreatic ductal adenocarcinoma, melanoma, and other advanced solid tumors. YH001 is being developed for hepatocellular carcinoma (HCC), non-small-cell lung carcinoma (NSCLC), and other solid tumors.

Executives

Bvcf Realization Fund, L.p.	2201 Interest of corporation controlled by you
Zhao Yin Guo Ji Jin Rong You Xian Gong Si	2201 Interest of corporation controlled by you
Zhao Yin Guo Ji Jin Rong Kong Gu You Xian Gong Si	2201 Interest of corporation controlled by you
Prowell Ventures Pte Ltd	2201 Interest of corporation controlled by you
Gic Special Investments Private Limited	2102 Investment manager
Gic Private Limited	2201 Interest of corporation controlled by you
Gic (ventures) Pte. Ltd.	2201 Interest of corporation controlled by you
Yang Zhi	2201 Interest of corporation controlled by you
Innoveda Medtech, Ltd.	2201 Interest of corporation controlled by you
Ni Jian
Bvcf Realization Fund Gp, Ltd.	2201 Interest of corporation controlled by you
Bioveda China Fund Ii Rmb, Limited	2101 Beneficial owner
Cmbi Private Equity Series Spc	2201 Interest of corporation controlled by you
Cmb International Private Investment Limited	2201 Interest of corporation controlled by you
Cmb International Investment Management Limited	2201 Interest of corporation controlled by you

Biocytogen Pharmaceuticals (Beijing) Co Headlines

No Headlines